Caixin
Apr 19, 2022 09:57 PM
OPINION

Opinion: China’s Covid-19 mRNA Vaccine Challenge

China plans to develop its own mRNA vaccine to control the production chain and lower the cost.
China plans to develop its own mRNA vaccine to control the production chain and lower the cost.

As the omicron variant of Covid-19 sweeps across China in the latest wave of the pandemic, the development of homegrown vaccines again stepped into the spotlight.

Since March, a rising tide of virus flare-ups has forced a number of Chinese cities into lockdown, including the Asian financial hub Shanghai. As China fights its worst outbreak since Wuhan, progress by domestic drugmakers in the development of Covid-19 vaccines based on the advanced mRNA technology made headlines.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code